2,473 Shares in CME Group Inc. $CME Bought by Triasima Portfolio Management inc.

Triasima Portfolio Management inc. purchased a new stake in CME Group Inc. (NASDAQ:CME) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,473 shares of the financial services provider’s stock, valued at approximately $668,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Empowered Funds LLC grew its stake in CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after buying an additional 1,037 shares during the last quarter. Diversified Trust Co boosted its holdings in shares of CME Group by 147.4% in the 2nd quarter. Diversified Trust Co now owns 2,590 shares of the financial services provider’s stock worth $714,000 after acquiring an additional 1,543 shares in the last quarter. Farther Finance Advisors LLC grew its position in CME Group by 2.2% during the 2nd quarter. Farther Finance Advisors LLC now owns 5,626 shares of the financial services provider’s stock worth $1,551,000 after acquiring an additional 120 shares during the last quarter. Park Avenue Securities LLC increased its holdings in CME Group by 62.0% during the 2nd quarter. Park Avenue Securities LLC now owns 21,829 shares of the financial services provider’s stock valued at $6,017,000 after purchasing an additional 8,355 shares in the last quarter. Finally, U.S. Capital Wealth Advisors LLC raised its position in CME Group by 3.9% in the 2nd quarter. U.S. Capital Wealth Advisors LLC now owns 40,307 shares of the financial services provider’s stock valued at $11,109,000 after purchasing an additional 1,500 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on the company. Rothschild & Co Redburn increased their target price on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a report on Thursday, November 6th. Jefferies Financial Group decreased their price objective on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Piper Sandler raised their price objective on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. UBS Group reiterated a “neutral” rating on shares of CME Group in a research report on Tuesday, January 6th. Finally, Barclays increased their price target on shares of CME Group from $280.00 to $304.00 and gave the company an “equal weight” rating in a research note on Friday, December 12th. Ten analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, CME Group has an average rating of “Hold” and an average price target of $291.82.

CME Group Stock Performance

CME Group stock opened at $282.54 on Tuesday. The company has a market cap of $101.88 billion, a PE ratio of 27.29, a PEG ratio of 3.14 and a beta of 0.27. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1 year low of $230.19 and a 1 year high of $290.79. The company’s 50-day moving average is $274.25 and its two-hundred day moving average is $271.82.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business posted $2.68 earnings per share. CME Group’s revenue was down 3.0% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Insider Activity

In other news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William R. Shepard bought 251 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The stock was purchased at an average cost of $278.37 per share, with a total value of $69,870.87. Following the completion of the purchase, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This represents a 0.10% increase in their position. The SEC filing for this purchase provides additional information. 0.30% of the stock is owned by corporate insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.